Search Results

Smoking rates stall in King County, while 1-in-4 12th graders uses tobacco - Enumclaw Courier-Herald

Bloomberg's fizzling with soda war - New York Daily News

Follow-up Avastin shown to benefit colon cancer patients - Chicago Tribune

In Study, Drug Delays Worsening of Breast Cancer, With Fewer Side Effects - New York Times

Interrupting Prostate Cancer Treatment Could Shorten Life, Study Finds - New York Times

A pageant of pink at Race for the Cure - Washington Post

Global cancer rate to surge 75% by 2030 - Vancouver Sun

New Cancer Drugs Use Body's Own Defenses - Wall Street Journal

Miami 'Zombie Apocalypse' Puts Bath Salts Ban in Congressional Spotlight - U.S. News & World Report

In Rat Experiment, New Hope for Spine Injuries - New York Times

Study: 'Smart bomb' drug attacks breast cancer

Doctors have successfully dropped the first "smart bomb" on breast cancer, using a drug to deliver a toxic payload to tumor cells while leaving healthy ones alone.

Study: 'Smart bomb' drug attacks breast cancer

Doctors have successfully dropped the first "smart bomb" on breast cancer, using a drug to deliver a toxic payload to tumor cells while leaving healthy ones alone.

Follow-up Avastin shown to benefit colon cancer patients

CHICAGO (Reuters) - Colorectal cancer patients treated with a follow-up round of Avastin fare better than those given chemotherapy alone after their disease has worsened, according to results of a large clinical trial. Avastin, sold by Roche, is approved as a first-line or second-line treatment for colorectal cancer, but not for both. Sales of the drug, also known as bevacizumab, totaled $5.3 billion Swiss francs ($5.5 billion) last year. ...

Armed antibody delays spread of certain breast cancers

CHICAGO (Reuters) - A study of Roche's experimental "armed antibody" found it extended the length of time breast cancer patients lived without their disease getting worse, marking the second successful pivotal trial in this new class of cancer drugs. The drug, TDM-1, uses Roche's antibody drug Herceptin to deliver a potent cell-killing payload developed by ImmunoGen directly into cancer cells, with the aim of boosting drug response while lowering the risk of side effects. ...

Allergies Linked to Higher Cancer Risk: Study

By JESSICA YARBER, M.D. Can allergies increase your risk of cancer? A new study out of University of Washington Fred Hutchinson Cancer Research Center suggests this may be the case. Specifically, the study found that patients with allergies may have a higher risk of developing...

Follow-up Avastin shown to benefit colon cancer patients

Armed antibody delays spread of certain breast cancers

J&J hormone-blocking pill slows prostate cancer spread

Bristol immune drug shows promise in three cancers

Hospitals fight drug scarcity, fear patients harmed

Mammary duct ectasia: A noncancerous breast condition

Butter vs. margarine: Which is better for my heart?

Helping children understand Alzheimer's

Vegetable juice: As good as whole vegetables?

Lung CT scan for cancer: Should you be screened?

Barefoot Running Can Be Great, but Tread Carefully

IVF at Young Age May Raise Breast Cancer Risk

Cooking on Back Burners Better for Indoor Air?

Arm and Hand Exercises for Stroke Rehab

Stroke Recovery and Arm Rehab: Important Questions

Stroke Recovery: Tips for the Caregiver

Medications to Reduce Arm Spasticity After a Stroke

Q&A With Marcus Samuelsson

Salmonella Outbreak Again Tied to Ohio Hatchery

Diabetes Drug Actos Again Linked to Bladder Cancer